1-2 of 2
Donna Griffith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nivolumab and Ibrutinib for Treatment of Patients with Refractory or Relapsed Central Nervous System Lymphoma

Jason Westin, Ranjit Nair, Luis Fayad, Swami P. Iyer, Luis Malpica, Sattva S. Neelapu, Felipe Samaniego, Raphael Eric Steiner, Paolo Strati, Shivon Mathew, Donna Griffith, Loretta J. Nastoupil, Wirt Montinez, Maria Alma Rodriguez, Frederick Hagemeister, Lei Feng, Francisco Vega, Christopher R. Flowers, Sairah Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 1721.
https://doi.org/10.1182/blood-2023-191123
Published: 2023
Journal Articles

Campath-IH Combined with Fludarabine/Cyclophophamide/Rituximab (FCR) as Conditioning for Unrelated Non-Myeloablative Hematopoietic Transplantation (NMT) for Non-Hodgkin’s Lymphoma (NHL): Low Mortality Rate and Lower Than Expected Incidence of Cytomegalovirus (CMV) Reactivation.

Issa F. Khouri, MD, Jeffrey J. Tarrand, MD, Grace-Julia Okoroji, MS, Rima M. Saliba, PhD, Chitra M. Hosing, MD, Daniel R. Couriel, MD, Partow Kebriaei, MD, Donna Griffith, RN, Gabriela Rondon, MD, Cindy Ippoliti, PharmD, Richard E. Champlin, MD
Journal: Blood
Blood (2005) 106 (11): 2902.
https://doi.org/10.1182/blood.V106.11.2902.2902
Published: 2005